Effectiveness and Feasibility of Complementary Lung-RADS Version 1.1 in Risk Stratification for pGGN in LDCT Lung Cancer Screening in a Chinese Population.
Qingcheng MengPengfei RenPengrui GaoXinmin DouXuejun ChenLan-Wei GuoYongping SongPublished in: Cancer management and research (2020)
Complementary Lung-RADS 1.1 is superior to Lung-RADS 1.1 and would be beneficial for LC screening of LDCT in China.